163 related articles for article (PubMed ID: 34522245)
21. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
[TBL] [Abstract][Full Text] [Related]
23. LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis.
Zeng Z; Zhao G; Zhu H; Nie L; He L; Liu J; Li R; Xiao S; Hua G
Cancer Cell Int; 2020; 20():350. PubMed ID: 32742197
[TBL] [Abstract][Full Text] [Related]
24. LINC00963 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma by Interacting with miR-10a to Upregulate SKA1 Expression.
Hu D; Ma A; Lu H; Gao Z; Yu Y; Fan J; Liu S; Wang Y; Zhang M
Appl Biochem Biotechnol; 2024 Mar; ():. PubMed ID: 38507172
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway.
Zhang C; Wang M; Shi C; Shi F; Pei C
Biosci Trends; 2018 Jul; 12(3):309-316. PubMed ID: 29952351
[TBL] [Abstract][Full Text] [Related]
26. Long Non-Coding RNA BANCR Promotes Endometrial Cancer Cell Proliferation and Invasion by Regulating MMP2 and MMP1 via ERK/MAPK Signaling Pathway.
Wang D; Wang D; Wang N; Long Z; Ren X
Cell Physiol Biochem; 2016; 40(3-4):644-656. PubMed ID: 27898420
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
28. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
Wang L; Shang X; Feng Q
Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA H19 mediates ovarian cancer cell cisplatin-resistance and migration during EMT.
Wu Y; Zhou Y; He J; Sun H; Jin Z
Int J Clin Exp Pathol; 2019; 12(7):2506-2515. PubMed ID: 31934077
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma.
Zhou T; Gao Y
World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762
[TBL] [Abstract][Full Text] [Related]
31. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
Wang DY; Li N; Cui YL
Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
[TBL] [Abstract][Full Text] [Related]
32. [FOXD2-AS1 is corelated with clinicopathological parameter of laryngeal carcinoma and promote cancer cell proliferation].
Chen W; Sun SG; Jiang MX; Li SS; Yuan K
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 33(5):436-440. PubMed ID: 31163553
[No Abstract] [Full Text] [Related]
33. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
34. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
35. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
Wang J; Jia J; Zhou L
Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
[TBL] [Abstract][Full Text] [Related]
37. lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway.
Wang Y; Gu J; Lin X; Yan W; Yang W; Wu G
Oncol Lett; 2018 Apr; 15(4):5865-5870. PubMed ID: 29552216
[TBL] [Abstract][Full Text] [Related]
38. [Study on the effect and mechanisms of SIGLEC-15 on laryngeal squamous cell carcinoma].
Li SH; Sun J; Chen W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 57(6):724-731. PubMed ID: 35725316
[No Abstract] [Full Text] [Related]
39. lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR.
Huang Q; Zhang D; Diao Q; Lin M
Oncol Lett; 2019 Sep; 18(3):2917-2922. PubMed ID: 31452772
[TBL] [Abstract][Full Text] [Related]
40. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
